The 10 Biggest Rounds Of October, And What The First Generation Of Teletherapy Got Wrong

[Crunchbase News]( November 5, 2022 [1]( [The 10 Biggest Rounds Of October: LanzaTech Locks Up $500M, Form Energy Powers Up With $450M]( Funding rounds were smaller in October, as cleantech and energy saw big raises, but biotech played a starring role as investors kept the faith. [October Funding →]( [2]( [Here’s What The First Generation Of Teletherapy Got Wrong]( Teletherapy funding surpassed $1.4 billion worldwide so far in 2022, a huge spike from past years, according to Crunchbase data. [Teletherapy's Spike →]( [3]( [SaaS Class Of 2021 Is Down But Not Out]( Most of the factors that conspired last year to make it a crazy bullish period for SaaS offerings have reversed. How low did they go? A Crunchbase analysis of 18 funded SaaS companies that debuted on U.S. exchanges last year shows an average decline of 58%. [SaaS Drops →]( [4]( [Web3 Funding Sees Huge Drop As Big Rounds Dip]( Funding to VC-backed Web3 startups, as well as the number of deals, dropped to its lowest since the end of 2020, with the sector mirroring the venture market in general. [Web3 Startups →]( [5]( [After A Lot Of Hype, (Useful) AI May Finally Be Here]( Artificial intelligence has once again become a hot buzzword in tech, even somewhat knocking off the malaise the venture capital markets have been under in the last several quarters. We look at what's happened in the sector so far this year. [Useful AI →]( [6]( [Biotech IPOs Are Strange, Even In A Down Market]( Few of the record 143 biotech startups that made their public debut last year had a product to sell. We unpack the odd nature of biotech IPOs. [Biotech IPOs →]( [Privacy Policy]( | [Terms of Service]( | [View in Browser]( | [Unsubscribe]( Crunchbase, Inc. 564 Market Street, Suite 700 San Francisco, CA 94104